Delta variant outbreaks in the US affect Össur sales
The negative developments in Q3 have caused Össur to downgrade its full year guidance to the lower boundary of its previous guidance interval.
By Marketwire, TRANSLATED by DANIEL PEDERSEN
The Covid-19 pandemic, and in particular, the outbreaks of the highly contagious Delta variant, is affecting sales at medtech company Össur.
Already a subscriber?Log in here
Read the whole article
Get access for 14 days for free. No credit card is needed, and you will not be automatically signed up for a paid subscription after the free trial.
With your free trial you get:
- Access all locked articles
- Receive our daily newsletters
- Access our app
Get full access for you and your coworkers
Start a free company trial todayRelated articles:
Össur key market sales normalize during second quarter
For subscribers
Össur advances in all areas after Covid-19-affected year
For subscribers
.jpg&w=384&q=75)
